Panel Discussion – Different Viewpoints of Bi & Multi Specifics in the Field

Time: 9:00 am
day: Day One


  • Comparing and contrasting CD3 bispecifics versus new T cell targets for a better understanding of the different avenues available
  • Progression of the bispecific antibodies towards multi-specificity and moving from bi to tri to tetra specific antibodies
  • Sharing thoughts on how to drive the cell therapy field into a new era of more accessible ‘curative’ therapies